Fairmount Funds Management LLC bought APGE
August 7, 2026 · Form 4 insider transaction
Fairmount Funds Management LLC bought 31,838 shares of Apogee Therapeutics, Inc. at $17.00 per share, a transaction worth $541.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
31,838
Price
$17.00
Total value
$541.2K
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 7, 2026
Filing dateAugust 11, 2026
Shares owned after330,485
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund II L.P. The managers of Fairmount are Peter Harwin and Tomas Kiselak. Fairmount, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.